Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

P Bossi; A T Chan; L Licitra; A Trama; E Orlandi; E P Hui; J Halámková; S Mattheis; B Baujat; J Hardillo; L Smeele; C van Herpen; A Castro; J-P Machiels; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org; EURACAN

doi:10.1016/j.annonc.2020.12.007

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up^†

Ann Oncol. 2021 Apr;32(4):452-465. doi: 10.1016/j.annonc.2020.12.007. Epub 2020 Dec 25.

Authors

P Bossi¹, A T Chan², L Licitra³, A Trama⁴, E Orlandi⁵, E P Hui², J Halámková⁶, S Mattheis⁷, B Baujat⁸, J Hardillo⁹, L Smeele¹⁰, C van Herpen¹¹, A Castro¹², J-P Machiels¹³; ESMO Guidelines Committee. Electronic address: [email protected]; EURACAN

Affiliations

¹ Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia, Italy.
² State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, People's Republic of China.
³ Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, Milan, Italy.
⁴ Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
⁵ Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
⁶ Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
⁷ Department of Otorhinolaryngology Head and Neck Surgery, University Hospital Essen, Essen, Germany.
⁸ Sorbonne University, APHP, Department of ENT - Head and Neck Surgery, Tenon Hospital, Paris, France.
⁹ Department of ENT - Head and Neck Surgery, Erasmus Medical Center Rotterdam, Rotterdam.
¹⁰ Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
¹¹ Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
¹² Administration Board of Centro Hospitalar e Universitário do Algarve, Portugal.
¹³ Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Institut de Recherche Clinique et Expérimentale (POLE MIRO), Université Catholique de Louvain, Brussels, Belgium.

PMID: 33358989
DOI: 10.1016/j.annonc.2020.12.007

No abstract available

Keywords: Clinical Practice Guidelines; diagnosis; follow-up; nasopharyngeal cancer; treatment.

Publication types

Practice Guideline

MeSH terms

Follow-Up Studies
Humans
Medical Oncology*
Nasopharyngeal Carcinoma / diagnosis
Nasopharyngeal Carcinoma / epidemiology
Nasopharyngeal Carcinoma / therapy
Nasopharyngeal Neoplasms* / diagnosis
Nasopharyngeal Neoplasms* / epidemiology
Nasopharyngeal Neoplasms* / therapy
Neoplasm Staging
Societies, Medical